Skip to main content
placeholder image

A phase I, dose escalation study to determine the maximum tolerated dose of erlotinib when combined with pertuzumab in previously treated non-small-cell lung cancer patients

Journal Article


Abstract


UOW Authors


  •   Ranson, Marie (external author)

Publication Date


  • 2008

Citation


  • Felip, E., Ranson, M., Cedres, S., Dean, E., De Droogh, E., Brewster, M., . . . Galdermans, D. (2008). A phase I, dose escalation study to determine the maximum tolerated dose of erlotinib when combined with pertuzumab in previously treated non-small-cell lung cancer patients. Journal of Clinical Oncology, 26(15_suppl), 19134. doi:10.1200/jco.2008.26.15_suppl.19134

Web Of Science Accession Number


Start Page


  • 19134

End Page


  • 19134

Volume


  • 26

Issue


  • 15_suppl

Abstract


UOW Authors


  •   Ranson, Marie (external author)

Publication Date


  • 2008

Citation


  • Felip, E., Ranson, M., Cedres, S., Dean, E., De Droogh, E., Brewster, M., . . . Galdermans, D. (2008). A phase I, dose escalation study to determine the maximum tolerated dose of erlotinib when combined with pertuzumab in previously treated non-small-cell lung cancer patients. Journal of Clinical Oncology, 26(15_suppl), 19134. doi:10.1200/jco.2008.26.15_suppl.19134

Web Of Science Accession Number


Start Page


  • 19134

End Page


  • 19134

Volume


  • 26

Issue


  • 15_suppl